Results 161 to 170 of about 153,260 (300)

Clinical efficacy of novel combinations of older beta-lactam and beta-lactamase inhibitors: Where are the evidences?

open access: gold, 2021
Balaji Veeraraghavan   +3 more
openalex   +1 more source

Fecal carriage and phylo-diversity of community-acquired blaTEM Enteric bacilli in Southwest Nigeria

open access: yesInfection and Drug Resistance, 2018
Paul Akinniyi Akinduti,1 Grace Iyabo Olasehinde,1 Oluwaseun Ejilude,2 Olugbenga Samson Taiwo,1 Yemisi Dorcas Obafemi1 1Microbiology Unit, Department of Biological Sciences, Covenant University, Otta, Nigeria; 2Microbiology Unit, Sacred Heart Hospital ...
Akinduti PA   +4 more
doaj  

Punica granatum leaf extract as a natural antibacterial agent explored by experimental and computational methods

open access: yesScientific Reports
The rise of multidrug-resistant (MDR) microorganisms, particularly Escherichia coli, poses a significant threat to global public health, necessitating the development of alternative treatments.
Faria Tasnim   +11 more
doaj   +1 more source

In vitro evaluation of SF-2103A, A novel carbapenem antibiotic, as a .BETA.-lactamase inhibitor.

open access: bronze, 1986
TOMIZO NIWA   +6 more
openalex   +2 more sources

Emergence of carbapenem, beta-lactamase inhibitor and cefoxitin resistant lineages from a background of ESBL-producing Klebsiella pneumoniae and K. quasipneumoniae highlights different evolutionary mechanisms [PDF]

open access: gold, 2018
Eva Heinz   +10 more
openalex   +1 more source

Novel inhibitors of beta-lactamase [PDF]

open access: yesActa Crystallographica Section A Foundations and Advances, 2015
Daria Beshnova   +8 more
openaire   +1 more source

Home - About - Disclaimer - Privacy